SO
RCKT icon

STRS Ohio’s Rocket Pharmaceuticals RCKT Stock Holding History

STRS Ohio’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,600
Closed -$56K – 2057
2024
Q2 		$56K Buy
2,600
+900
+53% +$20.7K ﹤0.01% 1787
2024
Q1 		$45K Buy
+1,700
New +$48.3K ﹤0.01% 1773
2023
Q2 		– Sell
-600
Closed -$10K – 2069
2023
Q1 		$10K Hold
600
– – ﹤0.01% 1902
2022
Q4 		$11K Buy
+600
New +$11.1K ﹤0.01% 1917
2019
Q2 		– Sell
-6,300
Closed -$110K – 2190
2019
Q1 		$110K Buy
6,300
+700
+13% +$11.1K ﹤0.01% 1777
2018
Q4 		$82K Hold
5,600
– – ﹤0.01% 1796
2018
Q3 		$137K Sell
5,600
-500
-8% -$10.8K ﹤0.01% 1781
2018
Q2 		$119K Buy
+6,100
New +$115K ﹤0.01% 1829
2016
Q3 		– Sell
-1,450
Closed -$45.6K – 1949
2016
Q2 		$43K Buy
+1,450
New +$51K ﹤0.01% 1794

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

STRS Ohio's RCKT Position: Q3 2024 in Review

STRS Ohio sold out of Rocket Pharmaceuticals (RCKT) in Q3 2024, closing a stake of 2,600 shares — an estimated $56K sold.

STRS Ohio first reported a position in RCKT in Q2 2016 and held it in 9 quarters. The position peaked at $137K in Q3 2018. 191 funds tracked by Wall St. Rank hold RCKT as of Q3 2024.

  • STRS Ohio reported no remaining Rocket Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • STRS Ohio sold 2,600 Rocket Pharmaceuticals shares in Q3 2024, an estimated $56K.
  • STRS Ohio first reported a position in Rocket Pharmaceuticals in Q2 2016 and held it in 9 quarters.
  • STRS Ohio's Rocket Pharmaceuticals position peaked at $137K in Q3 2018.
  • 191 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2024.

Based on STRS Ohio's 13F filing for Q3 2024, filed 1 Nov 2024.